Skip to content

Welcome to Discover Pharma! Today is : November 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development

    Centrix and University of Sussex launch £375,000 data science project for drug development

    Centrix Pharma Solutions and the University of Sussex are using [...]

    August 26, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development

    How AI is reshaping clinical trials: Saama on the next phase of regulated AI

    Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]

    August 26, 2026
  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    MRI study suggests some prostate cancer biopsies could eventually be avoided

    A study of 880 men found clinically significant prostate cancer [...]

    August 26, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Polaryx advances Phase 2 trial of PLX-200 in four rare diseases

    Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]

    August 26, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Lumen Bioscience gets up to $7M to advance LMN-1001 into Phase 1

    Lumen Bioscience has received up to $7m in US government [...]

    August 25, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data,Research & Development,Therapeutic Areas

    Brainomix to present five ILD studies on quantitative CT at ERS Congress

    Brainomix will present five studies examining quantitative CT biomarkers in [...]

    August 25, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Genespire starts international MMA study to support GENE202 development

    Genespire has started enrolling children with severe methylmalonic acidemia in [...]

    August 25, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Insilico launches open consortium to assess AI drug discovery benchmarks

    Insilico Medicine has launched an open consortium and benchmark index [...]

    August 24, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FDA grants Fast Track designation to Erasca pancreatic cancer drug

    The FDA has granted Fast Track designation to Erasca’s investigational [...]

    August 24, 2026
  • Drug Discovery & Development,Research & Development

    Anthropic AI protein designs undergo large-scale experimental validation

    Anthropic’s Claude AI models generated protein binders against 15 targets, [...]

    August 24, 2026
Previous789Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nabsys launches RepX for repeat expansion analysis
    Categories: Genomics and sequencing
  • NICE recommends maralixibat for Alagille syndrome itching
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Mursla Bio validates liver-specific liquid biopsy platform
    Categories: Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top